Fusion Proteins Comprising Factor Ix For Prophylactic Treatment Of

Fusion Proteins Comprising Factor Ix For Prophylactic Treatment Of Hemophilia And Methods Thereof

Abstract: The present invention relates to prophylactic dosing regimens with long acting factor IX (FIX) in dosing intervals of 1 week or longer including (but not limited to) 10 days or longer such as two weeks three weeks or even monthly.

Patent Information

Application #

Filing Date

21 June 2016

Publication Number

36/2016

Publication Type

INA

Invention Field

BIOTECHNOLOGY

Status

Email

patent@depenning.com

Parent Application

Applicants

CSL LIMITED

45 Poplar Road, Parkville, Victoria 3052

Inventors

1. JACOBS, Iris

424 Ashton Drive, King of Prussia, PA 19406

2. BENSEN KENNEDY, Debra

80 Horseshoe Point, Phoenixville, PA 19460

3. VOIGT, Christine

315 Highland Ave, Devon, PA 19333

Specification

SOFT COPY ATTACHED IN PDF

Documents

Application Documents

#	Name	Date
1	Sequence listing [21-06-2016(online)].pdf	2016-06-21
2	PROOF OF RIGHT [21-06-2016(online)].pdf	2016-06-21
3	Power of Attorney [21-06-2016(online)].pdf	2016-06-21
4	Form 5 [21-06-2016(online)].pdf	2016-06-21
5	Form 3 [21-06-2016(online)].pdf	2016-06-21
6	Form 1 [21-06-2016(online)].pdf	2016-06-21
7	Drawing [21-06-2016(online)].pdf	2016-06-21
8	Description(Complete) [21-06-2016(online)].pdf	2016-06-21
9	201647021167.pdf	2016-06-24
10	201647021167-Power of Attorney-270616.pdf	2016-07-27
11	201647021167-Correspondence-PA-Assignment-270616.pdf	2016-07-27
12	201647021167-Assignment-270616.pdf	2016-07-27
13	Form 3 [20-12-2016(online)].pdf	2016-12-20
14	Form 3 [05-05-2017(online)].pdf	2017-05-05